---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-24-000063"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2024-03-12T23:59:59+00:00"
generated_at: "2026-06-04T23:12:49.164991+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Clover Health FY 2023 net loss improves to $213.4M; Insurance MCR drops to 81.2%

## Summary
- Full-year 2023 net loss of $213.4M vs $339.6M in 2022; Insurance MCR improved to 81.2% from 91.8%.
- Adjusted EBITDA loss narrowed to $44.7M in 2023 from $290.4M in 2022.
- Q4 2023 revenue $510.3M; Insurance revenue grew 12% YoY to $303.1M.
- FY 2024 guidance: Insurance MCR 79%-83%; up to $20M Adjusted EBITDA profitability at the high end.
- Adjusted SG&A (non-GAAP) of $302.0M in FY 2023, down from $312.5M in FY 2022.

## SEC filing metadata
- accession: 0001801170-24-000063
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2024-03-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000063/0001801170-24-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000063/clov-20240312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-24-000063
- JSON: https://secwatch.observer/filing/0001801170-24-000063.json
- Plain text: https://secwatch.observer/filing/0001801170-24-000063.txt

## Key facts
- Earnings Releases
  CLOVER HEALTH INVESTMENTS, CORP. /DE reported fourth quarter and full year ended December 31, 2023 results: revenue $510.3 million, net income net loss of $70.5 million. Guidance initiated.
  - Period: fourth quarter and full year ended December 31, 2023
  - Revenue: $510.3 million
  - Net income: net loss of $70.5 million
  - Guidance: initiated
  - Result: reported results
  source text: will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights. For the fourth quarter 2023, the Company reported revenue of $510.3 million and net loss of $70.5 million, with full-year revenue of $2,033.7 million and net loss of $213.4 million. Adjusted EBITDA during 2023 improved to a loss of $19.1 million in the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000063/0001801170-24-000063-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.